Last updated: 2025-12-08 15:48:01 ET
Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron, that just showed positive results from a Phase 2 trial.
Boston, Dec. 04, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, "Global Market for Hydrogen Pipeline" is projected to re...
On today's episode of CNBC Crypto World, major cryptocurrencies rise as investors look to fend off crypto's selling pressure. Plus, Binance appoints co-founder Yi He as co-CEO alongside Richard Teng. And, Paul Grewal of Coinbase discusses what he int...
OpenAI is set to award $40.5 million to over 200 nonprofits by the end of the year
Tilbury Douglas has appointed Jack Dixon as managing director of its Paragon fitout arm. Dixon joins from Structure Tone London, where he spent more t...
Glendale, CA, Dec. 02, 2025 (GLOBE NEWSWIRE) -- As the US cryptocurrency casino market expands beyond $12 billion in annual transaction volume, Am...
U.S. companies Anduril and Palantir are finding money and a proximity to operational military structures in Warsaw's military boost.
